Category: Defiance ETFs IBBJ

Defiance ETFs Launches IBBJ, the Junior Biotechnology ETF

Defiance ETFs LLC announces the launch of the Defiance Nasdaq Junior Biotechnology ETF ( IBBJ). IBBJ tracks the Nasdaq Junior Biotechnology Index, offering investors exposure to small and mid-cap “junior” companies with a market capitalization below $5 billion.

“At Defiance, we believe in providing the next generation of investors with targeted exposure to disruptive themes. IBBJ does just that, offering exposure to the junior disruptors in the biotech space, and allowing investors to express either a short- or long-term view.” says Matthew Bielski, Chief Executive Officer at Defiance ETFs.

“Nasdaq works with a global community of healthcare leaders, including 98% of U.S. listed biotech companies,” said Cameron Lilja, Vice President and Head of Index Research and Development for Nasdaq Global Indexes. “The Nasdaq Junior Biotechnology Index allows investors to track the performance of small and mid-cap biotechnology companies, and our work with Defiance ETFs empowers investors with access to this important center of innovation.”

Read more at Business Wire

Want to work with us?

A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot.

Contact us